Pitfalls in defining and quantifying cachexia

Journal of Cachexia, Sarcopenia and Muscle

Volumn 2, Issue 2, 2011, Pages 71-73

  Baracos, Vickie E ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; INTERLEUKIN 2; INTERLEUKIN 6; TRIACYLGLYCEROL;

ANTHROPOMETRY; CACHEXIA; COMPUTER ASSISTED TOMOGRAPHY; CONCEPTUAL FRAMEWORK; DUAL ENERGY X RAY ABSORPTIOMETRY; EDITORIAL; FOOD INTAKE; GLUCOSE TOLERANCE; HEALTH CARE DISPARITY; HUMAN; IMPEDANCE; LEAN BODY WEIGHT; PRIORITY JOURNAL; SKIN TEST; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

EID: 84862878298     PISSN: 21905991     EISSN: 21906009     Source Type: Journal    
DOI: 10.1007/s13539-011-0031-9     Document Type: Editorial

References (11)

1. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011; 12: 489-95.
2. Muscaritoli M, Anker SD, Argilés J, Aversa Z, Bauer JM, Biolo G, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clin Nutr. 2010; 29: 154-9.
3. Evans WJ, Morley JE, Argilés J, Bales C, Baracos V, Guttridge D, et al. Cachexia: a new definition. Clin Nutr. 2008; 27: 793-9.
4. Fox KM, Brooks JM, Gandra SR, Markus R, Chiou CF. Estimation of cachexia among cancer patients based on four definitions. J Oncol. 2009; 2009: 693458.
5. Bozzetti F, Mariani L. Defining and classifying cancer cachexia: a proposal by the SCRINIO Working Group. JPEN J Parenter Enteral Nutr. 2009; 33: 361-7.
6. Fearon KC, Voss AC, Hustead DS, Cancer Cachexia Study Group. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr. 2006; 83: 1345-50.
7. Read JA, Crockett N, Volker DH, MacLennan P, Choy ST, Beale P, et al. Nutritional assessment in cancer: comparing the Mini-Nutritional Assessment (MNA) with the scored Patient-Generated Subjective Global Assessment (PGSGA). Nutr Cancer. 2005; 53: 51-6.
8. Argilés JM, López-Soriano FJ, Toledo M, Betancourt A, Serpe R, Busquets S. The cachexia score (CASCO): a new tool for staging cachectic cancer patients. J Cachexia Sarcopenia Muscle 2011; doi: 10. 1007/s13539-011-0027-5.
9. Knudsen AK, Aass N, Fainsinger R, Caraceni A, Klepstad P, Jordhøy M, et al. Classification of pain in cancer patients-a systematic literature review. Palliat Med. 2009; 23: 295-308.
10. Fainsinger RL, Nekolaichuk C, Lawlor P, Hagen N, Bercovitch M, Fisch M, et al. An international multicentre validation study of a pain classification system for cancer patients. Eur J Cancer. 2010; 46: 2896-904.
11. von Haehling S, Morley JE, Coats AJS, Anker SD. Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle. J Cachexia Sarcopenia Muscle. 2010; 1: 7-8.